pharmadog
News
when
  • Latest
  • Archive
by source
  • All Sources
  • Sources Page
Jobs
department
  • Clinical
  • Regulatory
  • Medical Affairs
  • Commercial
  • R&D / Discovery
  • Biostatistics / Data
  • Manufacturing / CMC
  • Market Access
therapeutic area
  • Oncology
  • Immunology
  • Neuroscience
  • Cardiovascular
  • Metabolic
  • Rare Disease
  • Infectious Disease
location & type
  • Remote Only
  • US Only
  • California
  • Massachusetts
  • Internships
  • Phase 3 Roles
  • All Jobs →
Sign InSubscribe
pharmadog

fetch the data · sniff the signal

Discover
  • Jobs
  • News
Hubs
  • Topics
  • Patent cliff
  • Publications
Tools
  • Compare
  • Search
  • Bookmarks
Trust
  • About
  • Sources
  • Contact
Legal
  • Privacy
  • Terms
  • Pricing

© 2026 pharmadog.xyz

made by humans and a good dog

  • home
  • jobs
  • news
  • search

calendar

5,063 catalysts · 5,063 phase readout · 2,308 8k filing · 316 pdufa · 271 earnings · 108 phase 2 completion · 50 phase 1 completion

★ save view↓export CSV
next 91 dayslessmore
MonWedFri
2026-07-27: 0 catalysts2026-07-28: 0 catalysts2026-07-29: 12 catalysts2026-07-30: 12 catalysts2026-07-31: 3 catalysts2026-08-01: 0 catalysts2026-08-02: 0 catalysts2026-08-03: 4 catalysts2026-08-04: 12 catalysts2026-08-05: 14 catalysts2026-08-06: 10 catalysts2026-08-07: 1 catalyst2026-08-08: 0 catalysts2026-08-09: 0 catalysts2026-08-10: 1 catalyst2026-08-11: 1 catalyst2026-08-12: 1 catalyst2026-08-13: 0 catalysts2026-08-14: 0 catalysts2026-08-15: 0 catalysts2026-08-16: 0 catalysts2026-08-17: 0 catalysts2026-08-18: 1 catalyst2026-08-19: 0 catalysts2026-08-20: 0 catalysts2026-08-21: 0 catalysts2026-08-22: 0 catalysts2026-08-23: 0 catalysts2026-08-24: 0 catalysts2026-08-25: 0 catalysts2026-08-26: 0 catalysts2026-08-27: 0 catalysts2026-08-28: 0 catalysts2026-08-29: 0 catalysts2026-08-30: 0 catalysts2026-08-31: 0 catalysts2026-09-01: 1 catalyst2026-09-02: 0 catalysts2026-09-03: 0 catalysts2026-09-04: 0 catalysts2026-09-05: 0 catalysts2026-09-06: 0 catalysts2026-09-07: 0 catalysts2026-09-08: 0 catalysts2026-09-09: 0 catalysts2026-09-10: 0 catalysts2026-09-11: 0 catalysts2026-09-12: 0 catalysts2026-09-13: 0 catalysts2026-09-14: 0 catalysts2026-09-15: 0 catalysts2026-09-16: 0 catalysts2026-09-17: 0 catalysts2026-09-18: 0 catalysts2026-09-19: 0 catalysts2026-09-20: 0 catalysts2026-09-21: 0 catalysts2026-09-22: 0 catalysts2026-09-23: 0 catalysts2026-09-24: 0 catalysts2026-09-25: 0 catalysts2026-09-26: 0 catalysts2026-09-27: 0 catalysts2026-09-28: 0 catalysts2026-09-29: 0 catalysts2026-09-30: 0 catalysts2026-10-01: 0 catalysts2026-10-02: 0 catalysts2026-10-03: 0 catalysts2026-10-04: 0 catalysts2026-10-05: 0 catalysts2026-10-06: 0 catalysts2026-10-07: 0 catalysts2026-10-08: 0 catalysts2026-10-09: 0 catalysts2026-10-10: 0 catalysts2026-10-11: 0 catalysts2026-10-12: 0 catalysts2026-10-13: 0 catalysts2026-10-14: 0 catalysts2026-10-15: 0 catalysts2026-10-16: 0 catalysts2026-10-17: 0 catalysts2026-10-18: 0 catalysts2026-10-19: 0 catalysts2026-10-20: 1 catalyst2026-10-21: 0 catalysts2026-10-22: 1 catalyst2026-10-23: 0 catalysts2026-10-24: 0 catalysts2026-10-25: 0 catalysts
view
agendamonth
show past →
sort
soonestlatesttypesponsoralpha
type: device recall×type: phase readout×clear all
type
  • phase readout5,063
  • 8k filing2,308
  • pdufa316
  • earnings271
  • phase 2 completion108
  • phase 1 completion50
phase 1 2 completion
28
  • phase 1 initiation22
  • phase 0 trial completion21
  • phase 1 2 initiation9
  • therapy area

    no tagged catalysts yet

    Date TBD

    50
    ›RECRUITINGphase readoutNCT07462312: MentalGym™ and NeuroBrave™ Guided Wearable-Assisted Physiology Regulation Training for PTSD (PRTP)

    Sponsor: NeuroBrave ltd.. Phase: NA. Conditions: PTSD - Post Traumatic Stress Disorder

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT02224781: Dabrafenib and Trametinib Followed by Ipilimumab and Nivolumab or Ipilimumab and Nivolumab Followed by Dabrafenib and Trametinib in Treating Patients With Stage III-IV BRAFV600 Melanoma

    Sponsor: National Cancer Institute (NCI). Phase: PHASE3. Conditions: Clinical Stage III Cutaneous Melanoma AJCC v8, Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Recurrent Melanoma, Unresectable Melanoma

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07623330: Use of TEE Derived Measurement vs Direct Measurement Under General Anesthesia in Assessment of Pressure Gradient in Peri Membranous Ventricular Septal Defect

    Sponsor: Ain Shams University. Phase: . Conditions: Peri Membranous Ventricular Septal Defect

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07254728: A Study to Evaluate Vaxart's Oral Bivalent GI.1/GII.4 Norovirus Vaccine in Healthy Lactating Females and Their Nursing Infants

    Sponsor: Vaxart. Phase: PHASE1. Conditions: Norovirus Infections

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07448467: Investigation of the Effectiveness of Progressive Resistance Exercise Training in the Management of Lymphedema.

    Sponsor: Uskudar University. Phase: NA. Conditions: Lymphedema, Breast Cancer

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT07575100: Maitland Mobilization Versus Therapeutic Ultrasound on Trismus Following Third Molar Surgery

    Sponsor: Cairo University. Phase: NA. Conditions: Postoperative Trismus

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT05847192: Tau Networks in Psychotic Alzheimer's Disease

    Sponsor: Northwell Health. Phase: . Conditions: Alzheimer Disease, Alzheimer Disease With Delusions, Alzheimer Disease With Psychosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07232992: Serratus Posterior Superior Intercostal Plane Block for Postoperative Analgesia in Open-Heart Surgery

    Sponsor: Bursa City Hospital. Phase: NA. Conditions: Serratus Posterior Superior Intercostal Plane Block (SPSIPB), Open-heart Surgery

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04554992: Convalescent Plasma for the Treatment of COVID-19 (Coronavirus Disease 2019)

    Sponsor: The Methodist Hospital Research Institute. Phase: PHASE1. Conditions: Covid19

    full page →ctgov ↗
    ›SUSPENDEDphase readoutNCT02130492: A Pilot Study Treatment of Malignant Tumors Using [18F] Fluorodeoxyglucose (FDG)

    Sponsor: Weill Medical College of Cornell University. Phase: PHASE1. Conditions: Advanced Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07325136: A Study to Assess the Safety and Tolerability of BMS-986525 Alone and in Combination Therapy in Participants With Relapsed/Refractory Small Cell Lung Cancer

    Sponsor: Bristol-Myers Squibb. Phase: PHASE1. Conditions: Relapsed/Refractory Small Cell Lung Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT04259892: Viral Excretion in Contact Subjects at High/Moderate Risk of Coronavirus 2019-nCoV Infection. COVID-19.

    Sponsor: Institut National de la Santé Et de la Recherche Médicale, France. Phase: . Conditions: Coronavirus

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05907811: General Anesthesia and General Anesthesia Combined With Thoracic Epidural Anesthesia

    Sponsor: Yuzuncu Yil University. Phase: NA. Conditions: Thoracic Epidural Analgesia, Gastric Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07304271: Intraperitoneal Paclitaxel and Systemic Therapy Versus Systemic Therapy Alone in Gastric Cancer Patients With Peritoneal Metastasis

    Sponsor: Magnus Nilsson. Phase: PHASE3. Conditions: Gastric Cancer Peritoneal Metastases

    full page →ctgov ↗
    ›ENROLLING_BY_INVITATIONphase readoutNCT07424144: An Extension Study to Investigate the Long-term Safety and Tolerability of Itepekimab in Adult Participants With Inadequately Controlled Chronic Rhinosinusitis With Nasal Polyps

    Sponsor: Sanofi. Phase: PHASE3. Conditions: Chronic Rhinosinusitis With Nasal Polyps

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07226609: A Dietary Study for People With Multiple Myeloma

    Sponsor: Memorial Sloan Kettering Cancer Center. Phase: NA. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07294664: PD1/TGFβ In Combination With SHR2554 or Apatinib And Chemotherapy For First - Line Treatment Of Gastric Cancer

    Sponsor: The First Affiliated Hospital of Zhengzhou University. Phase: PHASE2. Conditions: Advanced Gastric Cancer, SHR1701

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT04363164: Sequential Testosterone and Enzalutamide Prevents Unfavorable Progression

    Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins. Phase: PHASE2. Conditions: Castration Resistant Metastatic Prostate Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05680363: Prospective Sibling Oocyte Study of a New Method to Improve Embryo Development in IVF/ICSI Patients

    Sponsor: Fecundis S.A.. Phase: NA. Conditions: Infertility

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07184463: A Study of Pain Reduction After Pulmonary Resection by RATS-TT, RATS-OTC, and Hybrid RATS.

    Sponsor: Centre hospitalier de l'Université de Montréal (CHUM). Phase: . Conditions: Thoracic Surgery, Video-assisted Thoracic Surgery, Robotic-assisted Thoracic Surgery

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06052163: Bumetanide in Patients With Alzheimer's Disease

    Sponsor: Stanford University. Phase: PHASE2. Conditions: Alzheimer Disease

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07283263: A Study to Evaluate the Safety, Tolerability, and Drug Levels of BMS-986521 in Healthy Participants.

    Sponsor: Bristol-Myers Squibb. Phase: PHASE1. Conditions: Healthy Volunteers

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05870787: iMproving thE DIagnostics And Treatment Of ceRvical Precancer

    Sponsor: University of Aarhus. Phase: . Conditions: Cervical Dysplasia, Cervical Disease, Cervical Lesion, Cervical Cancer, Cervical Neoplasm

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT05831787: COVID19 OutcomeS in Myeloma and the Impact of VaCcines

    Sponsor: ASH Research Collaborative. Phase: . Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›ACTIVE_NOT_RECRUITINGphase readoutNCT04136353: Darolutamide Augments Standard Therapy for Localised Very High-Risk Cancer of the Prostate

    Sponsor: University of Sydney. Phase: PHASE3. Conditions: Prostate Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06982131: A Study Investigating the Safety of RO7795081 and the Effect of RO7795081 on How the Body Processes Pitavastatin and Rosuvastatin in Otherwise Healthy Overweight or Obese Adult Participants

    Sponsor: Hoffmann-La Roche. Phase: PHASE1. Conditions: Overweight, Obesity

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07387237: Multigene Germline Panel Testing in Gastric Cancer Patients in Portugal

    Sponsor: Unidade Local De Saúde Do Norte Alentejano. Phase: . Conditions: Gastric Cancer (Diagnosis), Stomach Cancer

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06100237: Teclistamab in Combination With Daratumumab for High-Risk Smoldering Myeloma: A Clinical and Correlative Phase 2 Immuno-Oncology Study (the REVIVE Study)

    Sponsor: Carl Ola Landgren, MD, PhD. Phase: PHASE2. Conditions: Multiple Myeloma

    full page →ctgov ↗
    ›TERMINATEDphase readoutNCT06560645: A Study of PRT7732, an Oral SMARCA2 Degrader, in Patients With Advanced or Metastatic Solid Tumors With a SMARCA4 Mutation

    Sponsor: Prelude Therapeutics. Phase: PHASE1. Conditions: Advanced Solid Tumor, Metastatic Solid Tumor, Non-small Cell Lung Carcinoma, SMARCA4 Mutation, Esophageal Adenocarcinoma, Esophageal Squamous Cell Carcinoma, Gastric Adenocarcinoma, Gastric Squamous Cell Carcinoma, Gastroesophageal Junction Adenocarcinoma, Gastroesophageal Junction Squamous Cell Carcinoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06011733: A Study to Evaluate the Efficacy and Safety of Bimekizumab in Chinese Adult Study Participants With Moderate to Severe Plaque Psoriasis

    Sponsor: UCB Biopharma SRL. Phase: PHASE3. Conditions: Chronic Plaque Psoriasis, Moderate to Severe Chronic Plaque Psoriasis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06151847: Lifileucel With Reduced Dose Fludarabine/Cyclophosphamide Lymphodepletion and Interleukin-2 for the Treatment of Patients With Unresectable or Metastatic Melanoma

    Sponsor: University of Kansas Medical Center. Phase: PHASE2. Conditions: Clinical Stage IV Cutaneous Melanoma AJCC v8, Metastatic Melanoma, Pathologic Stage IIIC Cutaneous Melanoma AJCC v8, Unresectable Melanoma

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03986047: Effect of Thermal Therapy and Exercises on Acute Low Back Pain

    Sponsor: Laval University. Phase: NA. Conditions: Low Back Pain

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07548658: Mind Mapping: Impact on Critical Thinking and Problem-Solving Skills

    Sponsor: Gazi University. Phase: NA. Conditions: Mind Mapping, Nursing Students, Critical Thinking

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07543458: Therapeutics for Moderate and Severe Dengue

    Sponsor: Oxford University Clinical Research Unit, Vietnam. Phase: PHASE3. Conditions: Dengue, Severe Dengue, Mosquito-Borne Diseases, Vector Borne Diseases, Arbovirus Infections, Flavivirus Infections, RNA Virus Infections, Hemorrhagic Fever

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06662058: Remote Audiometry to Monitor for Treatment-Related Hearing Loss in Patients With H&N SCC Receiving Cisplatin and/or Radiation

    Sponsor: Emory University. Phase: NA. Conditions: Clinical Stage IV HPV-Mediated (p16-Positive) Oropharyngeal Carcinoma AJCC v8, Cutaneous Squamous Cell Carcinoma of the Head and Neck, Head and Neck Carcinoma of Unknown Primary, Head and Neck Squamous Cell Carcinoma, Hypopharyngeal Squamous Cell Carcinoma, Laryngeal Squamous Cell Carcinoma, Metastatic Cutaneous Squamous Cell Carcinoma of the Head and Neck, Metastatic Head and Neck Squamous Cell Carcinoma, Metastatic Hypopharyngeal Squamous Cell Carcinoma, Metastatic Laryngeal Squamous Cell Carcinoma, Metastatic Nasopharyngeal Squamous Cell Carcinoma, Metastatic Oral Cavity Squamous Cell Carcinoma, Metastatic Oropharyngeal Squamous Cell Carcinoma, Metastatic Paranasal Sinus Squamous Cell Carcinoma, Nasopharyngeal Squamous Cell Carcinoma, Oral Cavity Squamous Cell Carcinoma, Oropharyngeal Squamous Cell Carcinoma, Paranasal Sinus Squamous Cell Carcinoma, Recurrent Cutaneous Squamous Cell Carcinoma of the Head and Neck, Recurrent Head and Neck Squamous Cell Carcinoma, Recurrent Hypopharyngeal Squamous Cell Carcinoma, Recurrent Laryngeal Squamous Cell Carcinoma, Recurrent Nasopharyngeal Squamous Cell Carcinoma, Recurrent Oral Cavity Squamous Cell Carcinoma, Recurrent Oropharyngeal Squamous Cell Carcinoma, Recurrent Paranasal Sinus Squamous Cell Carcinoma, Stage IV Cutaneous Squamous Cell Carcinoma of the Head and Neck AJCC v8, Stage IV Hypopharyngeal Carcinoma AJCC v8, Stage IV Laryngeal Cancer AJCC v8, Stage IV Lip and Oral Cavity Cancer AJCC v8, Stage IV Nasopharyngeal Carcinoma AJCC v8, Stage IV Oropharyngeal (p16-Negative) Carcinoma AJCC v8, Stage IV Sinonasal Cancer AJCC v8

    ›ACTIVE_NOT_RECRUITINGphase readoutNCT05864248: Feasibility Study SA of the Supira System for HRPCI

    Sponsor: Supira Medical. Phase: NA. Conditions: Heart Diseases, Coronary Artery Disease (CAD), Heart Failure

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT06912555: Effect of Low-calorie Diets With Different Macronutrient Composition and Macronutrient Distribution in Shift Workers With Prediabetes or Type 2 Diabetes and Overweight or Obesity.

    Sponsor: Universidad de Zaragoza. Phase: NA. Conditions: Type 2 Diabetes, Overweight or Obesity, PreDiabetes

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07415655: Modulation of Cerebral Ischemia by Albumin

    Sponsor: University Hospital Hradec Kralove. Phase: PHASE2. Conditions: Ischemic Stroke

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06246955: Acceptance and Commitment Therapy and Compassion-Based Virtual Group Therapy to Improve Psychological Wellbeing in Patients With Cancer

    Sponsor: Mayo Clinic. Phase: NA. Conditions: Hematopoietic and Lymphoid System Neoplasm, Malignant Solid Neoplasm

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06843226: A Study in Children and Teenagers to Learn if a TDV Dengue Vaccination Lowers the Chance of Hospital Stays for Dengue

    Sponsor: Takeda. Phase: . Conditions: Dengue Fever

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07420478: TF-CBT for Autistic Youth Pilot Implementation - Open Pilot

    Sponsor: Dartmouth-Hitchcock Medical Center. Phase: NA. Conditions: Autism Spectrum Disorder, PTSD and Trauma-related Symptoms, Autism, Trauma and Stressor Related Disorders, Mental Health Services

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07164378: International Study of the SING IMT™ Prosthesis in Pseudophakic patiEnts With Stable Moderate to Profound Bilateral Central vIsion Impairment Due to adVancEd AMD / PERSPECTIVE Study

    Sponsor: VisionCare, Inc.. Phase: NA. Conditions: Age - Related Macular Degeneration (AMD)

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06620185: GEneRating Mucosal Immunity After INfluenzA Infection and Vaccination in Lung and Lymphoid TissuE

    Sponsor: Imperial College London. Phase: NA. Conditions: Influenza

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT06680843: Characterization of Human Immune Signatures to Zoonotic Virus Exposure in Cambodia

    Sponsor: National Institute of Allergy and Infectious Diseases (NIAID). Phase: . Conditions: Immunity, Humoral

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT07616843: STANDARDIZATION OF THE PROTOCOL FOR ATTENUATION COEFFICIENT MEASUREMENT

    Sponsor: Fondazione IRCCS Policlinico San Matteo di Pavia. Phase: . Conditions: Liver Steatosis

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT03850743: Biomarker Signatures of the Sleep-pain Enigma

    Sponsor: Defense and Veterans Center for Integrative Pain Management. Phase: . Conditions: Post Surgical Pain and Sleep Impairment

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07441343: Effects of Polyphenol Supplementation and Exercise on Physical Performance in Older Adults

    Sponsor: Dr. Chris McGlory, PhD. Phase: NA. Conditions: Sarcopenia, Aging, Frailty

    full page →ctgov ↗
    ›RECRUITINGphase readoutNCT07377643: IBI354 With or Without Pertuzumab Versus Taxane, Trastuzumab and Pertuzumab in HER2-positive Metastatic Breast Cancer

    Sponsor: Innovent Biopharmaceutical Technology (Hangzhou) Co., LTD.. Phase: PHASE3. Conditions: HER2-positive Breast Cancer

    full page →ctgov ↗
    ›COMPLETEDphase readoutNCT01942343: Akathisia in Post Operative Outpatients Surgery

    Sponsor: University Hospital, Strasbourg, France. Phase: PHASE3. Conditions: Akathisia

    full page →ctgov ↗
    ›NOT_YET_RECRUITINGphase readoutNCT07642843: CM336 for Active Sjogren's Syndrome Study

    Sponsor: Keymed Biosciences Co.Ltd. Phase: PHASE1. Conditions: Primary Sjögren's Syndrome (pSS)

    full page →ctgov ↗
    ← prev
    page 96 of 102
    next →
    full page →
    ctgov ↗